Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease

Overview of attention for article published in Frontiers in immunology, June 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 17 news outlets
twitter: 4 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 35 Mendeley

Summary News X Wikipedia Dimensions citations

So far, Altmetric has seen 17 news stories from 17 outlets.

免疫原性の専門家で前FDAのAmy Rosenberg博士がEpiVaxに参画

ZDNet Japan, 07 Jul 2021

AsiaNet 90490 （1547）【プロビデンス（米ロードアイランド州）2021年7月6日PR Newswire＝共同通信JBN】EpiVax, Inc.（「EpiVax」）は、Amy Rosenberg博士が20年以上にわたり率いてきた米食品医薬品…

Immunogenicity Expert and FDA Alum Dr. Amy Rosenberg Joins EpiVax

Biospace, 06 Jul 2021

PROVIDENCE, R.I., July 6, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to announce that Dr.

News story from Finanz Nachrichten on Tuesday 06 July 2021

Finanz Nachrichten, 06 Jul 2021

Immunogenicity Expert and FDA Alum Dr. Amy Rosenberg Joins EpiVax

adnkronos, 06 Jul 2021

PROVIDENCE, R.I., July 6, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to announce that Dr.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 13 additional news stories.